Overview

Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

Status:
Completed
Trial end date:
2006-01-31
Target enrollment:
Participant gender:
Summary
Allow gynecologists to gain experience with arcoxia for treatment of dysmenorrhea.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Etoricoxib